Alpha Teknova, Inc. (TKNO)


-0.14 (-4.35%)
Symbol TKNO
Price $2.965
Beta -0.078
Volume Avg. 0.10M
Market Cap 120.758M
Shares () -
52 Week Range 1.62-6.48
1y Target Est -
DCF Unlevered TKNO DCF ->
DCF Levered TKNO LDCF ->
Operating Margin -
Debt / Equity -
P/E -2.15 Sell
P/B -


Consensus EPS

Upgrades & Downgrades

Latest TKNO news

Mr. Stephen Gunstream
Drug Manufacturers—Specialty & Generic
NASDAQ Global Market

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.